Interest Expense of THC Therapeutics, Inc. from 31 Oct 2010 to 30 Apr 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
THC Therapeutics, Inc. quarterly and annual Interest Expense in USD history and change rate from 31 Oct 2010 to 30 Apr 2024.
  • THC Therapeutics, Inc. Interest Expense for the quarter ending 30 Apr 2024 was $18,337, a 4.6% decline year-over-year.
  • THC Therapeutics, Inc. Interest Expense for the twelve months ending 30 Apr 2024 was $77,552, a 64% increase year-over-year.
  • THC Therapeutics, Inc. annual Interest Expense for 2023 was $79,577, a 21% decline from 2022.
  • THC Therapeutics, Inc. annual Interest Expense for 2022 was $100,402, a 82% decline from 2021.
  • THC Therapeutics, Inc. annual Interest Expense for 2021 was $551,750, a 13% increase from 2020.
Source SEC data
View on sec.gov
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

THC Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $77,552 $18,337 -$892 -4.6% 01 Feb 2024 30 Apr 2024 10-Q 13 Nov 2024 2024 Q3
Q4 2023 $78,444 $19,670 -$396 -2% 01 Nov 2023 31 Jan 2024 10-Q 05 Sep 2024 2024 Q2
Q3 2023 $78,840 $19,380 -$737 -3.7% 01 Aug 2023 31 Oct 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2023 $79,577 $20,165 +$32,223 01 May 2023 31 Jul 2023 10-K 26 Feb 2024 2023 FY
Q1 2023 $47,354 $19,229 -$22,515 -54% 01 Feb 2023 30 Apr 2023 10-Q 13 Nov 2024 2024 Q3
Q4 2022 $69,869 $20,066 -$9,462 -32% 01 Nov 2022 31 Jan 2023 10-Q 05 Sep 2024 2024 Q2
Q3 2022 $79,331 $20,117 -$21,071 -51% 01 Aug 2022 31 Oct 2022 10-Q 09 Aug 2024 2024 Q1
Q2 2022 $100,402 $12,058 -$264,604 -105% 01 May 2022 31 Jul 2022 10-K 26 Feb 2024 2023 FY
Q1 2022 $365,006 $41,744 -$53,655 -56% 01 Feb 2022 30 Apr 2022 10-Q 09 Jan 2024 2023 Q3
Q4 2021 $418,661 $29,528 -$60,469 -67% 01 Nov 2021 31 Jan 2022 10-Q 08 Jan 2024 2023 Q2
Q3 2021 $479,130 $41,188 -$72,620 -64% 01 Aug 2021 31 Oct 2021 10-Q 22 Dec 2022 2023 Q1
Q2 2021 $551,750 $252,546 +$120,998 +92% 01 May 2021 31 Jul 2021 10-K 25 Nov 2022 2022 FY
Q1 2021 $430,752 $95,399 -$35,696 -27% 01 Feb 2021 30 Apr 2021 10-Q 16 Jun 2022 2022 Q3
Q4 2020 $466,448 $89,997 -$22,837 -20% 01 Nov 2020 31 Jan 2021 10-Q 16 May 2022 2022 Q2
Q3 2020 $489,285 $113,808 +$1,585 +1.4% 01 Aug 2020 31 Oct 2020 10-Q 16 May 2022 2022 Q1
Q2 2020 $487,700 $131,548 +$2,054 +1.6% 01 May 2020 31 Jul 2020 10-K 31 Mar 2022 2021 FY
Q1 2020 $485,646 $131,095 -$69,298 -35% 01 Feb 2020 30 Apr 2020 10-Q 22 Jun 2021 2021 Q3
Q4 2019 $554,944 $112,834 +$133,362 01 Nov 2019 31 Jan 2020 10-Q 29 Mar 2021 2021 Q2
Q3 2019 $421,582 $112,223 +$117,996 01 Aug 2019 31 Oct 2019 10-Q 17 Dec 2020 2021 Q1
Q2 2019 $303,586 $129,494 +$319,808 01 May 2019 31 Jul 2019 10-K 04 Nov 2020 2020 FY
Q1 2019 $16,222 $200,393 +$171,664 +598% 01 Feb 2019 30 Apr 2019 10-Q 22 Jun 2020 2020 Q3
Q4 2018 $187,886 $20,528 -$51,380 -167% 01 Nov 2018 31 Jan 2019 10-Q 23 Mar 2020 2020 Q2
Q3 2018 $136,506 $5,773 -$34,814 -120% 01 Aug 2018 31 Oct 2018 10-Q 23 Dec 2019 2020 Q1
Q2 2018 $101,692 $190,314 01 May 2018 31 Jul 2018 10-K/A 18 Nov 2019 2020 FY
Q1 2018 $28,729 01 Feb 2018 30 Apr 2018 10-Q 14 Jun 2019 2019 Q3
Q4 2017 $30,852 01 Nov 2017 31 Jan 2018 10-Q 15 Mar 2019 2019 Q2
Q3 2017 $29,041 01 Aug 2017 31 Oct 2017 10-Q 19 Dec 2018 2019 Q1
Q1 2014 $3,019 $2,093 +$1,343 +179% 01 Feb 2014 30 Apr 2014 10-Q 12 Jun 2014 2013 Q3
Q4 2013 $1,676 $1,093 +$843 +337% 01 Nov 2013 31 Jan 2014 10-Q 12 Jun 2014 2013 Q2
Q3 2013 $833 $833 +$833 01 Aug 2013 31 Oct 2013 10-Q 11 Jun 2014 2013 Q1
Q2 2013 $0 $1,000 -$1,300 -433% 01 May 2013 31 Jul 2013 10-K 09 Jun 2014 2013 FY
Q1 2013 $1,300 $750 +$450 +150% 01 Feb 2013 30 Apr 2013 10-Q 12 Jun 2014 2013 Q3
Q4 2012 $850 $250 -$50 -17% 01 Nov 2012 31 Jan 2013 10-Q 12 Jun 2014 2013 Q2
Q3 2012 $900 $0 -$300 -100% 01 Aug 2012 31 Oct 2012 10-Q 11 Jun 2014 2013 Q1
Q2 2012 $1,200 $300 -$1,792 -86% 01 May 2012 31 Jul 2012 10-K 09 Jun 2014 2013 FY
Q1 2012 $2,992 $300 +$600 01 Feb 2012 30 Apr 2012 10-Q 11 Jun 2013 2013 Q3
Q4 2011 $2,392 $300 +$596 01 Nov 2011 31 Jan 2012 10-Q 21 Mar 2013 2013 Q2
Q3 2011 $1,796 $300 +$596 01 Aug 2011 31 Oct 2011 10-Q 14 Dec 2012 2013 Q1
Q2 2011 $1,200 $2,092 01 May 2011 31 Jul 2011 10-K 13 Nov 2012 2012 FY
Q1 2011 $300 01 Feb 2011 30 Apr 2011 10-Q 14 Jun 2012 2012 Q3
Q4 2010 $296 01 Nov 2010 31 Jan 2011 10-Q 21 Mar 2012 2012 Q2
Q3 2010 $296 01 Aug 2010 31 Oct 2010 10-Q 20 Dec 2011 2012 Q1

THC Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $79,577 -$20,825 -21% 01 Aug 2022 31 Jul 2023 10-K 26 Feb 2024 2023 FY
2022 $100,402 -$451,348 -82% 01 Aug 2021 31 Jul 2022 10-K 26 Feb 2024 2023 FY
2021 $551,750 +$64,050 +13% 01 Aug 2020 31 Jul 2021 10-K 25 Nov 2022 2022 FY
2020 $487,700 +$184,114 +61% 01 Aug 2019 31 Jul 2020 10-K 31 Mar 2022 2021 FY
2019 $303,586 +$405,278 01 Aug 2018 31 Jul 2019 10-K 04 Nov 2020 2020 FY
2018 $101,692 01 Aug 2017 31 Jul 2018 10-K/A 18 Nov 2019 2020 FY
2013 $0 -$1,200 -100% 01 Aug 2012 31 Jul 2013 10-K 09 Jun 2014 2013 FY
2012 $1,200 $0 0% 01 Aug 2011 31 Jul 2012 10-K 09 Jun 2014 2013 FY
2011 $1,200 01 Aug 2010 31 Jul 2011 10-K 13 Nov 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.